Company / Depreciation & Amortization
Cyclerion Therapeutics, Inc. Depreciation & Amortization History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$65.0K
FY2023
5-year range
$65.0K / $2.3M
FY2019-FY2023
Trend
+0.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2M to $65,000 over the past 2 years.
Based on SEC 10-K filings.
$65,000 in FY2023 with a 3-year CAGR of -71.1%.
Improved from $2M to $65,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -71.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -71.1%, indicating a declining trend.
- In FY2023, depreciation & amortization increased 0.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $65.0K | +0.0% |
| FY2022 | $65.0K | -97.2% |
| FY2021 | $2.3M | -14.9% |
| FY2020 | $2.7M | +76.7% |
| FY2019 | $1.5M | - |
As of FY2023 · SEC 10-K Annual Filings · Updated Jun 24, 2026